Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma
Abstract There is no recognized serum biomarker to predict the recurrence of endometrial carcinoma (EC). We aimed to explore serum human epididymis protein 4 (HE4) and cancer antigen 125 (CA125) as the biomarkers to predict and monitor recurrence of type II EC. 191 patients diagnosed with type II EC...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/689f3bf0919449cda19cfc08390a1656 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|